Bengaluru startup Mandrake Bio secured sixteen crore rupees in new funding. This capital will expand their AI and biophysics teams for platform validation. The company uses generative AI to design novel gene-editing enzymes. This technology promises faster development for improved crops and therapies. Mandrake Bio aims to significantly reduce gene-editing development timelines and costs.
Source: Read Full Article
